Ajer Jeffrey Robert has filed 25 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 8000 shares of NEKTAR THERAPEUTICS ($NKTR) on September 30, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2025 | NEKTAR THERAPEUTICS | $NKTR | Ajer Jeffrey Robert | Not found | A | Stock Option | 8000 | $0.00 | 8,000.0000 | 205,661,000 | 9999.99% | 0.00% |
| July 1, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Ajer Jeffrey Robert | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| April 7, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Ajer Jeffrey Robert | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 81,484,950 | 9999.99% | 0.05% |
| Sept. 18, 2024 | NEKTAR THERAPEUTICS | $NKTR | Ajer Jeffrey Robert | Not found | A | Stock Option | 120000 | $0.00 | 120,000.0000 | 190,001,000 | 9999.99% | 0.06% |
| April 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 300 | $68.65 | 71,767.0000 | 191,595,000 | 0.42% | 0.00% |
| May 2, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | S | Common Stock | 5000 | $82.91 | 66,767.0000 | 191,595,000 | 6.97% | 0.00% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | F | Common Stock | 22580 | $83.87 | 71,467.0000 | 191,595,000 | 24.01% | 0.01% |
| March 5, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | S | Common Stock | 4000 | $87.07 | 94,047.0000 | 191,595,000 | 4.08% | 0.00% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 21440 | $0.00 | 82,244.0000 | 191,595,000 | 35.26% | 0.01% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 9338 | $0.00 | 91,582.0000 | 191,595,000 | 11.35% | 0.00% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 6465 | $0.00 | 98,047.0000 | 191,595,000 | 7.06% | 0.00% |
| Aug. 16, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | S | Common Stock | 5000 | $90.00 | 60,804.0000 | 188,963,000 | 7.60% | 0.00% |
| April 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 318 | $66.88 | 65,804.0000 | 188,963,000 | 0.49% | 0.00% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 10110 | $0.00 | 89,967.0000 | 188,963,000 | 12.66% | 0.01% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | F | Common Stock | 3971 | $87.74 | 85,996.0000 | 188,963,000 | 4.41% | 0.00% |
| March 16, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | F | Common Stock | 20510 | $93.41 | 65,486.0000 | 188,963,000 | 23.85% | 0.01% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Stock Option (Right to buy Common Stock) | 23070 | $0.00 | 23,070.0000 | 188,963,000 | 9999.99% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 20760 | $0.00 | 61,848.0000 | 188,963,000 | 50.53% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 10380 | $0.00 | 72,228.0000 | 188,963,000 | 16.78% | 0.01% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | A | Common Stock | 7629 | $0.00 | 79,857.0000 | 188,963,000 | 10.56% | 0.00% |
| Jan. 25, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | M | Common Stock | 49000 | $67.81 | 90,088.0000 | 188,963,000 | 119.26% | 0.03% |
| Jan. 25, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | S | Common Stock | 44825 | $115.65 | 45,263.0000 | 188,963,000 | 49.76% | 0.02% |
| Jan. 25, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | S | Common Stock | 4175 | $116.15 | 41,088.0000 | 188,963,000 | 9.22% | 0.00% |
| Jan. 25, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | M | Stock Option (Right to buy Common Stock) | 2200 | $0.00 | 0.0000 | 188,963,000 | 100.00% | 0.00% |
| Jan. 25, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | M | Stock Option (Right to buy Common Stock) | 46800 | $0.00 | 0.0000 | 188,963,000 | 100.00% | 0.02% |